tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Graig Suvannavejh, 129 are a BUY (66.15%), 59 are a HOLD (30.26%), 7 are a SELL (3.59%).
Analyst Graig Suvannavejh, currently employed at MIZUHO, carries an average stock price target met ratio of 59.72% that have a potential upside of 34.05% achieved within 110 days.
Graig Suvannavejh’s has documented 422 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 13-Aug-2025.
Analyst best performing recommendations are on MNTA (MOMENTA PHARMACEUTICALS).
The best stock recommendation documented was for EYPT (EYEPOINT PHARMACEUTICALS) at 11/2/2023. The price target of $20 was fulfilled within 35 days with a profit of $12.71 (174.35%) receiving and performance score of 49.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$3.5
$0.98 (38.89%)
$9
1 months ago
(28-Jul-2025)
1/6 (16.67%)
$1.74 (98.86%)
24
Buy
$10
$7.48 (296.83%)
$7
3 months 19 days ago
(09-May-2025)
0/6 (0%)
$8.83 (754.70%)
Hold
$4
$1.48 (58.73%)
$15
8 months 12 days ago
(16-Dec-2024)
1/4 (25%)
$2.02 (102.02%)
128
Sell
$3
$0.48 (19.05%)
$10
9 months 2 days ago
(26-Nov-2024)
1/6 (16.67%)
$0.43 (16.73%)
332
Buy
$5
$2.48 (98.41%)
$16
9 months 2 days ago
(26-Nov-2024)
1/3 (33.33%)
$2.43 (94.55%)
70
Which stock is Graig Suvannavejh is most bullish on?
Which stock is Graig Suvannavejh is most reserved on?
What Year was the first public recommendation made by Graig Suvannavejh?
